Copyright © 2026 Authors retain the copyright of this article. This article is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

@article{187439,
        author = {Bharati Namdeorao Rathod and Shankar Bhagwan Khokle and Shruti Sunil Wankhade and VaIshnavi Raju Bawane and Trupti Amod Raut and Avinash S. Jiddewar and Gauri Uddhavrao Bhende},
        title = {A REVIEW ON PATHOPHYSIOLOGY, PHARMACOKINETICS AND TREATMENT OF PCOS THERAPY FOR PCOS-ANTIDIABETIC AGENTS},
        journal = {International Journal of Innovative Research in Technology},
        year = {2025},
        volume = {12},
        number = {6},
        pages = {4473-4478},
        issn = {2349-6002},
        url = {https://ijirt.org/article?manuscript=187439},
        abstract = {PCOS stands for polycystic ovary syndrome having another name also called as polycystic ovary disease, functional ovarian, hyperandrogenism, ovarian hyperthecosis, sclerocystic ovary syndrome. PCOS is an multi system disorder having symptoms such as insulin resistance, hyperandrogenism,etc also having long term metabolism risk atherosclerosis, cardiovascular complication, type 2 diabetes mellitus, etc.diagnostis study base on Rutherdam criteria. PCOS having etiology factor such as environment factor, diet, obesity, stress, hormonal changes, endocrine dysfunction,etc. pathophysiological factor mostly effect on insulin resistance, vitamin D deficiency, and heredity and genetic factor.Medication therapy involve drug such as Metformine, Thiazolidinedione and Vit D supliments},
        keywords = {},
        month = {November},
        }